Systemic Lupus Erythematosus (SLE)
113
50
57
26
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
4.4%
5 terminated out of 113 trials
83.9%
-2.6% vs benchmark
11%
12 trials in Phase 3/4
38%
10 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (113)
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
AZAHAR Study To Describe Anifrolumab in a Real-World Setting
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Mediterranean Diet and Gut Microbiota in Children With Systemic Lupus Erythematosus
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases